A detailed history of Woodmont Investment Counsel LLC transactions in Amgen Inc stock. As of the latest transaction made, Woodmont Investment Counsel LLC holds 2,228 shares of AMGN stock, worth $704,048. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,228
Previous 2,313 3.67%
Holding current value
$704,048
Previous $657,000 5.94%
% of portfolio
0.05%
Previous 0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$262.75 - $319.31 $22,333 - $27,141
-85 Reduced 3.67%
2,228 $696,000
Q4 2023

Jan 19, 2024

BUY
$255.7 - $288.46 $6,392 - $7,211
25 Added 1.09%
2,313 $666,000
Q3 2023

Oct 24, 2023

SELL
$218.65 - $271.46 $30,829 - $38,275
-141 Reduced 5.8%
2,288 $614,000
Q2 2023

Aug 02, 2023

SELL
$214.27 - $253.37 $79,279 - $93,746
-370 Reduced 13.22%
2,429 $539,000
Q1 2023

May 09, 2023

BUY
$225.79 - $275.2 $88,961 - $108,428
394 Added 16.38%
2,799 $676,000
Q4 2022

Jan 31, 2023

SELL
$229.03 - $291.01 $38,935 - $49,471
-170 Reduced 6.6%
2,405 $631,000
Q3 2022

Nov 08, 2022

BUY
$224.46 - $253.15 $63,971 - $72,147
285 Added 12.45%
2,575 $580,000
Q2 2022

Aug 09, 2022

SELL
$230.71 - $256.74 $35,990 - $40,051
-156 Reduced 6.38%
2,290 $557,000
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $57,229 - $63,310
-261 Reduced 9.64%
2,446 $591,000
Q4 2021

Feb 02, 2022

SELL
$198.88 - $227.6 $16,507 - $18,890
-83 Reduced 2.97%
2,707 $609,000
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $5,306 - $6,217
-25 Reduced 0.89%
2,790 $593,000
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $18,452 - $20,472
-79 Reduced 2.73%
2,815 $686,000
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $91,426 - $106,543
412 Added 16.6%
2,894 $720,000
Q4 2020

Feb 16, 2021

BUY
$216.38 - $257.67 $41,112 - $48,957
190 Added 8.29%
2,482 $571,000
Q3 2020

Nov 16, 2020

BUY
$234.65 - $260.95 $11,732 - $13,047
50 Added 2.23%
2,292 $583,000
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $47,870 - $58,743
242 Added 12.1%
2,242 $529,000
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $108,068 - $143,328
593 Added 42.15%
2,000 $405,000
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $20,813 - $26,752
110 Added 8.48%
1,407 $339,000
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $107,077 - $128,301
-615 Reduced 32.17%
1,297 $251,000
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $318,730 - $373,623
1,912 New
1,912 $352,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Woodmont Investment Counsel LLC Portfolio

Follow Woodmont Investment Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodmont Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Woodmont Investment Counsel LLC with notifications on news.